Product Information
METOCLOPRAMIDE 5 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.0358 per EA under NDC 50228023201. Its NADAC has been published 56 times since Sep 10, 2025.
FDA first approved this application on Jan 30, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228023201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOCLOPRAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA072215FDA Approved
1/30/1990
TE Code
AB
On Market Since
2/12/2025
Pharmacological Classes
Price Statistics
The NADAC for METOCLOPRAMIDE 5 MG TABLET has been published 56 times since Sep 10, 2025, and over the history we have for it it has declined 16.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0358 per EA |
|---|---|
| All-time high | $0.0433 (Jan 14, 2026) |
| All-time low | $0.0354 (Aug 19, 2026) |
| 52-week high | $0.0433 |
| 52-week low | $0.0354 |
| Median price | $0.0387 |
| Average price | $0.0397 |
| Largest weekly change | -6.0% (Feb 18, 2026) |
| Weeks tracked | 56 |
| Tracking since | Sep 10, 2025 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ScieGen Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metoclopramide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dopamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOCLOPRAMIDE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METOCLOPRAMIDE 5 MG TABLET, manufactured by ScieGen Pharmaceuticals, Inc., is $0.0358 per EA (NDC 50228023201), effective Sep 30, 2026.
How has the price of METOCLOPRAMIDE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for METOCLOPRAMIDE 5 MG TABLET has declined 16.4%. It has been tracked across 56 weekly CMS publications since Sep 10, 2025.
What are the highest and lowest recorded NADAC prices for METOCLOPRAMIDE 5 MG TABLET?
Since Sep 10, 2025, the NADAC for METOCLOPRAMIDE 5 MG TABLET has ranged from a low of $0.0354 (Aug 19, 2026) to a high of $0.0433 (Jan 14, 2026), with a median of $0.0387 per EA.
Are there cheaper alternatives to METOCLOPRAMIDE 5 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOCLOPRAMIDE 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METOCLOPRAMIDE 5 MG TABLET?
METOCLOPRAMIDE 5 MG TABLET (NDC 50228023201) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.